"CDE grants BTD to Innovent’s IBI343 for pancreatic cancer" was originally created and published by Pharmaceutical Technology ...

The phase 2 trial showed a 42% response rate with lete-cel in synovial sarcoma and MRCLS, with manageable adverse events.

Rezolute (RZLT) announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, to ersodetug, RZ358, for the treatment of hypoglycemia due to ...

The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...

Denali Therapeutics (DNLI) announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for ...

"FDA awards GSK breakthrough status for relapsed osteosarcoma treatment" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The informati ...

GSK (GSK) announced that the US Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for GSK5764227, GSK’227, ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced a significant milestone for its proprietary Nectin-4 targeted ADC (9MW2821). On January 8, 2025, ...

This BTD was granted based on clinical data from a Phase 2 exploratory dose-ranging trial for the treatment of Post-Surgical Pain following Total Knee Arthroplasty (TKA), or replacement.

Innovent Biologics, Inc., announced that the Center for Drug Evaluation (CDE) of China's National Medical Products ...

The Boston Transportation Department (BTD) thanks everyone who provided comments on the potential sites for new Bluebikes stations in East Boston, Charlestown, South Boston, and South Boston ...

San Francisco, US Friday, January 17, 2025, 09:00 Hrs [IST] ...